Mucoepidermoid carcinoma of the lung, response to EGFR inhibitors, EGFR and K-RAS mutations, and differential diagnosis
Authors:
- Giulio RossiGRGiulio Rossi
- Giuliana SartoriGSGiuliana Sartori
- Alberto CavazzaACAlberto Cavazza
- Stefano TamberiSTStefano Tamberi
- 1 January 2009
- journal article
- other
- Published by Elsevier in Lung Cancer
- Vol. 63 (1) , 159-160
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Mucoepidermoid carcinoma of lung: Potential target of EGFR-directed treatmentLung Cancer, 2008
- Mucoepidermoid Carcinoma of the Bronchus: A ReviewArchives of Pathology & Laboratory Medicine, 2007
- Necrotizing sialometaplasia versus invasive carcinoma of the head and neck: the use of myoepithelial markers and keratin subtypes as an adjunct to diagnosisHistopathology, 2007
- Identical epidermal growth factor receptor mutations in adenocarcinomatous and squamous cell carcinomatous components of adenosquamous carcinoma of the lungCancer, 2006
- MUC1, MUC2, MUC4, and MUC5AC Expression in Salivary Gland Mucoepidermoid CarcinomaAmerican Journal of Surgical Pathology, 2005
- Pulmonary Mucoepidermoid Carcinoma With Prominent Tumor-Associated Lymphoid ProliferationAmerican Journal of Surgical Pathology, 2005
- Mucoepidermoid tumors of the lungCancer, 1987